Update on vaccination guidelines for allergic children

References

• Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2007. Vital Health Stat. 10(239), 1–80 (2009).
   Google Scholar
• Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol.43(4), 649–655 (2000).
   PubMed Web of Science ®Google Scholar
• CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J, McIntyre L (Eds). Public Health Foundation, Washington DC, USA (2009).
   Google Scholar
• CDC. CDC Health Information for International Travel 2010. US Department of Health and Human Services, Public Health Service, Atlanta, GA, USA (2009).
   Google Scholar
• CDC. Guide to Vaccine Contraindications and Precautions (2009).
   Google Scholar
• Kelso JM. Adverse reactions to vaccines for infectious diseases. In: Middleton’s Allergy: Principles & Practice. Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FER (Eds). Mosby, PA, USA, 1189–1204 (2009).
   Google Scholar
• Bohlke K, Davis RL, Marcy SM et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics112(4), 815–820 (2003).
   PubMed Web of Science ®Google Scholar
• Wood RA, Berger M, Dreskin SC et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics122(3), e771–e777 (2008).
   PubMed Web of Science ®Google Scholar
• Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J. Allergy Clin. Immunol.91(4), 867–872 (1993).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J. Allergy Clin. Immunol.98(6 Pt 1), 1058–1061 (1996).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Yamanaka T, Ikeda K et al. IgE-mediated systemic reactions to gelatin included in the varicella vaccine. J. Allergy Clin. Immunol.99(2), 263–264 (1997).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy56(6), 536–539 (2001).
   PubMed Web of Science ®Google Scholar
• O’Brien TC, Maloney CJ, Tauraso NM. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. Appl. Microbiol.21(4), 780–782 (1971).
   PubMedGoogle Scholar
• James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N. Engl. J. Med.332(19), 1262–1266 (1995).
   PubMed Web of Science ®Google Scholar
• Baxter DN. Measles immunization in children with a history of egg allergy. Vaccine14(2), 131–134 (1996).
   PubMed Web of Science ®Google Scholar
• Red Book. Report of the Committee on Infectious Diseases. Pickering LK (Ed.). American Academy of Pediatrics, IL, USA (2009).
   Google Scholar
• James JM, Zeiger RS, Lester MR et al. Safe administration of influenza vaccine to patients with egg allergy. J. Pediatr.133(5), 624–628 (1998).
   PubMed Web of Science ®Google Scholar
• Zeiger RS. Current issues with influenza vaccination in egg allergy. J. Allergy Clin. Immunol.110(6), 834–840 (2002).
   PubMed Web of Science ®Google Scholar
• Kelso JM. Raw egg allergy – a potential issue in vaccine allergy. J. Allergy Clin. Immunol.106(5), 990 (2000).
   PubMed Web of Science ®Google Scholar
• DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; Team VAERS. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine24(6), 703–707 (2006).
   PubMed Web of Science ®Google Scholar
• Gardasil® (Human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant), package insert. Merck & Co., Inc., NJ, USA (2008).
   Google Scholar
• Lear JT, English JS. Anaphylaxis after hepatitis B vaccination. Lancet345(8959), 1249 (1995).
   PubMed Web of Science ®Google Scholar
• Russell M, Pool V, Kelso JM, Tomazic-Jezic VJ. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS). Vaccine23(5), 664–667 (2004).
   PubMed Web of Science ®Google Scholar
• Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy. Am. J. Dis. Child.147(2), 128–129 (1993).
   PubMedGoogle Scholar
• Zheng W, Dreskin SC. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. Ann. Allergy Asthma Immunol.99(6), 574–575 (2007).
   PubMed Web of Science ®Google Scholar
• FluMist® (Influenza Virus Vaccine Live, Intranasal), package insert. MedImmune, MD, USA (2008).
   Google Scholar
• Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis. J.23(2), 138–144 (2004).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med.356(7), 685–696 (2007).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age. Vaccine26(Suppl. 4), D10–D16 (2008).
   PubMed Web of Science ®Google Scholar
• Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J.21(1), 44–48 (2002).
   PubMed Web of Science ®Google Scholar
• Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J.25(10), 860–869 (2006).
   PubMed Web of Science ®Google Scholar
• Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr. Infect. Dis. J.27(5), 444–452 (2008).
   PubMed Web of Science ®Google Scholar
• Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm. Rep.57(RR-7), 1–60 (2008).
   PubMedGoogle Scholar
• Wharton M, Strikas RA, Harpaz R et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep.52(RR-7), 1–16 (2003).
   PubMedGoogle Scholar
• Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J. Allergy Clin. Immunol.113(3), 395–400 (2004).
   PubMed Web of Science ®Google Scholar
• Anderson HR, Poloniecki JD, Strachan DP et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health91(7), 1126–1129 (2001).
   PubMed Web of Science ®Google Scholar
• Koppen S, de Groot R, Neijens HJ, Nagelkerke N, van Eden W, Rumke HC. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine22(25–26), 3375–3385 (2004).
   PubMed Web of Science ®Google Scholar
• Syncope after vaccination – United States, January 2005–July 2007. MMWR Morb. Mortal. Wkly Rep.57(17), 457–460 (2008).
   PubMedGoogle Scholar
• Bohlke K, Davis RL, DeStefano F et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J. Allergy Clin. Immunol.113(3), 536–542 (2004).
   PubMed Web of Science ®Google Scholar
• Nakayama T, Aizawa C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J. Allergy Clin. Immunol.106(3), 591–592 (2000).
   PubMed Web of Science ®Google Scholar
• Zent O, Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine23(5), 579–584 (2004).
   PubMed Web of Science ®Google Scholar